Market Pulse
Structured intelligence on corporate strategy, market moves, and industry signals.
Each entry is a briefing, not a headline: event summary, strategic context, and what to watch next.
A Company Pulse is our reading of what a company says in its own press release, with the questions we would want answered. It is not verified reporting and it is not an endorsement. Pulses are made from press releases we collect from several sources, including Wire. Nobody can pay for a Pulse.
Idorsia received approval from Health Canada for JERAYGO (aprocitentan), its endothelin receptor antagonist, for treating resistant hypertension.
Read full analysis →
China entered the top 10 in the global innovation ranking for 2025, according to the World Intellectual Property Organization.
Read full analysis →
Aptiv PLC will release its fourth quarter 2025 financial results on February 2, 2026.
Read full analysis →
Bausch + Lomb completed a refinancing of $2.802 billion in outstanding Term B loans.
Read full analysis →
Viewbix Inc. (VBIX) is pursuing an acquisition of 85%-100% of Quantum X Labs Ltd., Israel’s multi-disciplinary quantum technology laboratory.
Read full analysis →
BridgeBio will host an investor webinar on January 9, 2026, at 8:00 am ET.
Read full analysis →
Nouveau Monde Graphite (NMG) is paying accrued interest on a convertible note issued in November 2022.
Read full analysis →
Bitfarms has entered into a definitive share purchase agreement to sell its 70 MW Paso Pe, Paraguay site to Sympatheia Power Fund (SPF).
Read full analysis →
DHT Holdings has taken delivery of a VLCC newbuilding, the DHT Antelope, from Hanwha Ocean.
Read full analysis →
FLSmidth completed the sale of its Air Pollution Control (APC) business to Rubicon Partners on December 30, 2025.
Read full analysis →
Princess Cruises featured a 55x21 foot float, 'Together in the Magic of Alaska,' at the 2026 Rose Parade.
Read full analysis →
iQIYI is launching its first global offline entertainment park, iQIYI LAND Yangzhou, on February 8, 2026.
Read full analysis →
Rosen Law Firm has filed a class action lawsuit against agilon health, inc. (AGL) on behalf of investors.
Read full analysis →
The VistaShares Animal Spirits 2x Daily Strategy ETF (WILD) is being closed and liquidated.
Read full analysis →
Outlook Therapeutics' resubmission of its Biologics License Application (BLA) for ONS-5010/LYTENAVA™ (bevacizumab-vikg) for wet AMD has been rejected with a Complete Response Letter (CRL) by the FDA.
Read full analysis →
Bridge tolls across seven Bay Area state-owned bridges will increase by 50 cents starting January 1, 2026, with phased increases continuing through 2030.
Read full analysis →
Voltalia has commenced construction on the Artemisya hybrid cluster in Uzbekistan, encompassing 100MW/200MWh of storage and 100MW of wind capacity.
Read full analysis →
First American Properties' CEO Michael Eisenga publicly praised economic and security gains during the first year of President Trump's second term.
Read full analysis →
China’s Supreme People’s Court upheld the validity of Novo Nordisk’s semaglutide compound patent, affirming a previous Beijing IP Court ruling.
Read full analysis →
The Generation Essentials Group (TGE) completed a de-SPAC merger with Black Spade Acquisition II Co in June 2025, listing on the NYSE and LSE.
Read full analysis →